MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Parkinson’s disease patients with cognitive impairment more sensitive to pain?

    K. Abe, K. Fukushima, K. Ando, Y. Maeda, R. Ishikura, H. Yoshikawa (Nishinomiya, Japan)

    Objective: To determine whether parkinson's disease (PD) patients with cognitive impairment is more sensitive for pain than PD patients without cognitive impairment. Background: PD patients…
  • 2017 International Congress

    Extended “Timed Up and Go”: A Clinical Indicator of Cognitive State in Parkinson’s Disease?

    T. Evans, A. Jefferson, M. Byrnes, S. Walters, S. Ghosh, F. Mastaglia, B. Power, R. Anderton (Perth, Australia)

    Objective: To evaluate an extended Timed Up and Go (extended-TUG) as a potential holistic indicator of Parkinson’s disease; hypothesised to correlate closely with disease severity…
  • 2017 International Congress

    Demographic and Clinical Characters of Parkinson’s Disease in Tertiary Hospital in Kuwait

    W. Kamel, J. Al Hashel, S. Ahmed (Kuwait, Kuwait)

    Objective: To estimate the prevalence of Idiopathic Parkinson’s disease (PD) within patients attending a movement disorder clinic at tertiary hospital in Kuwait Background: PD is…
  • 2017 International Congress

    Research participants are not representative of the population age distribution of PD

    A. Macleod, R. Henery, P. Nwajiugo, C. Counsell (Aberdeen, United Kingdom)

    Objective: To describe the distribution of the age at onset in PD incidence studies and to compare this with the age of onset of published…
  • 2017 International Congress

    Heart rate variability in Parkinson’s Disease and idiopathic REM sleep behavior disorder and relation with other non-motor symptoms

    P. Bugalho, M. Mendonça, T. Lampreia, R. Miguel, R. Barbosa, M. Salavisa (Lisbon, Portugal)

    Objective: To evaluate Heart Rate Variability (HRV) changes across sleep stages in Parkinson's Disease (PD) and idiopathic REM Sleep Behavior disorder (RBD) patients, and to…
  • 2017 International Congress

    Saliva changes and the oral health in Parkinson´s disease

    J. Tiigimäe-Saar, T. Tamme, P. Taba (Tartu, Estonia)

    Objective: The aim of this study was to determine the risk of change in the oral microflora and oral health in PD patients. Background: Parkinson…
  • 2017 International Congress

    Emergence of Non-motor Fluctuations with Reference to Motor Fluctuations in Parkinson’s Disease

    A. Kim, Y. Kim, A. Kim, C.W. Shin, B. Jeon, H. Kim (Seoul, Republic of Korea)

    Objective: To examine the timing of emergence of non-motor fluctuations (NMF) with reference to motor fluctuations (MF) in Parkinson’s Disease (PD). Background: NMF and MF…
  • 2017 International Congress

    Burden of autonomic neuropathy in Parkinson’s disease patients treated with advanced therapies

    A. Romagnolo, A. Merola, M. Rosso, C. Comi, C. Artusi, M. Rizzone, M. Zibetti, S. Maule, L. Lopiano, A. Espay (Turin, Italy)

    Objective: To analyze the prevalence and the functional burden of autonomic neuropathy (AN) in advanced Parkinson’s disease (PD) patients who underwent subthalamic deep brain stimulation…
  • 2017 International Congress

    Lower urinary tract symptoms in patients with Parkinson’s Disease: findings from a Tunisian cohort

    A. Nasri, M. Ben Djebara, Y. Sidhom, K. Achour, I. Kacem, A. Gargouri, R. Gouider (Manouba, Tunisia)

    Objective: To assess lower urinary tract symptoms (LUTS) in patients with Parkinson’s disease (PD) and to investigate their impact on the quality of Life (QoL).…
  • 2017 International Congress

    Speech and voice response to levodopa in late-stage Parkinson’s Disease patients: report from an acute levodopa challenge

    M. Fabbri, I. Guimarães, M. Coelho, R. Cardoso, L. Guedes, M. Rosa, C. Godinho, A. Antonini, J. Ferreira (Lisbon, Portugal)

    Objective: to assess the change of speech and voice after an acute L-dopa challenge in late-stage Parkinson’s disease (LSPD). Background: PD patients are classically affected…
  • « Previous Page
  • 1
  • …
  • 113
  • 114
  • 115
  • 116
  • 117
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley